Online Peer Support in Long-term Conditions
Launched by KING'S COLLEGE LONDON · Jan 15, 2024
Trial Information
Current as of July 06, 2025
Completed
Keywords
ClinConnect Summary
Approximately 20% of people with a long-term conditions (LTC) experience subthreshold depression (SUBD), which is also a key risk factor for developing more significant depression. There is currently no targeted psychological support for people with LTC also experiencing SUBD. This work offers a potentially novel way of addressing this gap through the delivery of an online peer support and psychoeducation platform. This project builds on previously funded work, which has enabled the co-production of a platform curated through cross-collaborations of people with LTC, clinicians, academics, a...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Probable SUBD (scoring 5-9 on the PHQ-8).
- • Currently living with one or more LTCs. A long-term condition is a diagnosed physical medical condition with a duration of ≥6 months that demonstrates recurrence or deterioration and is typically associated with a poor prognosis. There are no restrictions on the type of LTCs. Please see list below.
- • Aged ≥18 years old.
- • Access to the internet (via phone, desktop, or laptop).
- • Sufficient English to engage with the platform (assessed via self-report during screening).
- • Ability to give informed consent (i.e., no known circumstances/conditions that may affect capacity to consent, e.g., dementia, memory loss or awaiting diagnosis).
- Exclusion Criteria:
- • • Have ever received a clinical diagnosis of severe mental illness of bipolar, psychosis, post-traumatic stress disorder (PTSD), and/or schizophrenia, and/or a diagnosis of dementia.
About King's College London
King's College London is a prominent research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the college leverages its extensive expertise in medicine, neuroscience, and public health to conduct rigorous studies aimed at improving patient outcomes. As a sponsor of clinical trials, King's College London prioritizes ethical standards, participant safety, and scientific integrity, fostering an environment that encourages groundbreaking research and the translation of findings into clinical practice. Through its state-of-the-art facilities and a diverse network of researchers, the institution strives to address critical health challenges and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
Matthew Hotopf, PhD, FRCPsych, FMedSci
Principal Investigator
King's College London
Elly Aylwin-Foster, MSc
Study Director
King's College London
Ewan Carr, PhD
Study Director
King's College London
Vanessa Lawrence, PhD
Study Director
King's College London
Alan Simpson, PhD
Study Director
King's College London
Ciara Regan, MSc
Study Director
King's College London
Hannah G Jones, BSc
Study Director
King's College London
Grace Lavelle, PhD
Study Director
King's College London
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported